Atlas Trials

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma

Clinical trial NCT00017186 · COMPLETED

Trial details

NCT number
NCT00017186
Sponsor
Alliance for Clinical Trials in Oncology
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Mesothelioma
Start date
2001-07-01
Primary completion
2004-08-01
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.